Cardio Diagnostics announces issuance of patent from USPTO

Cardio Diagnostics announced that the U.S. Patent and Trademark Office has issued a notice of allowance to University of Iowa Research Foundation, or UIRF, for U.S. Application No. 17,857,723 titled Compositions and Methods for Detecting Predisposition to Cardiovascular Disease, which is exclusively licensed to the company from UIRF, and that was co-invented by Cardio Diagnostics’ founders, Meesha Dogan and Robert Philibert, the CEO and CMO of the company, respectively. This is the second U.S. patent being issued in this patent family. Patents in this patent family have also been issued in the European Union, China, India, and Australia.